South Africa's vaccination numbers have dropped significantly to an average of around 5,000 people a day
Time of Update: 2022-11-26
(End) On November 15, local time in South Africa, the Ministry of Health announced that since July this year, the average number of new crown pneumonia vaccinations in South Africa has dropped sharply, and it is basically maintained at an average level of about 5,000 people per day.
Lung Cancer Concern Month Science Popularization (1) What is the burden of lung cancer
Time of Update: 2022-11-25
2 JAMA sub-journal: In 2019, the global lung cancer burden ranked first among men and second in women Globally, in the past decade from 2010 to 2019, the incidence of TBL (trachea, bronchial and lung cancer) jumped from the original third place to the second place; Of the total cancer burden, TBL was the leading cause of cancer death (18.
Recommended reading: TB strikes back! Interpretation of the key points of the World Health Organization (WHO) Global Tuberculosis Report (2021
Time of Update: 2022-11-14
Guideline name: Interpretation of key points of the 2021 WHO Global Tuberculosis ReportEnglish:Publisher: Clinical Center for Tuberculosis Prevention and Control, Beijing Chest Hospital, Beijing Chest
Issue 35/2013 - Thailand proposes to ban the use of insecticides in consumer and agricultural products
Time of Update: 2022-11-12
(Xiaohua) Thailand intends to ban the use of insecticides in consumer goods and agricultural productsRecently, the Thai Food and Drug Administration issued a revised draft to reclassify the insecticide multi-worm as a Type 4 hazardous substance.
In 2022, the overall investment and financing trend in the medical and health field will slow down
Time of Update: 2022-10-20
In recent years, the research and development of domestic innovative drugs has been hot, but the targets are piled up, the track is crowded, and the involution is serious, which has caused the development of the innovative drug industry to fall into a bottleneck period, coupled with the impact of medical insurance control fees, the epidemic and other factors, the investment and financing in the domestic medical and health field are "deserted" compared with last year.
How can pharmaceutical companies achieve efficient and compliant pharmaceutical production? Follow Schneider Electric to experience the charm of digitalization
Time of Update: 2022-09-30
【Pharmaceutical Network Conference Forum】Traditional pharmaceutical enterprises often have defects such as low production efficiency and low production management level, and the rapid development of t
See 2021｜By-Health CEO Lin Zhicheng: The dietary supplement industry may usher in new growth opportunities
Time of Update: 2022-09-13
On the other hand, with the gradual introduction and implementation of relevant national policies, industry regulations, and standard construction, the supervision of the dietary supplement industry has become increasingly strict, and the degree of industry standardization and access thresholds have been further improved, which will have a negative impact on the long-term development and competition pattern of the industry.
An unprecedented "obesity crisis"! In 2030, the overweight/obesity rate in China may reach 70
Time of Update: 2022-09-07
And driven by obesity, by 2030, the number of people with type 2 diabetes may exceed 200 million!Status: One in every two adults is overweight/obeseSince the 1970s, China's overall economic level has grown rapidly, and the living standards of residents have improved rapidly, but various complex factors behind it have jointly promoted the increase in obesity and non-communicable diseases.
"Family Medicine Online" Health Science Popularization Media Platform Launched
Time of Update: 2022-09-03
(Sun Qing) Responsible editor: Xiao Zhihan Review: Peng Zonglu On January 7, the popular science website "Family Medicine Online" was officially launched, and the WeChat public account of "Family Medicine Online" was also launched simultaneously .
Yizumi Electric Injection Molding Machine Helps German Face Mask Production
Time of Update: 2022-08-24
The most recent successful case is the face shield produced by WeForm Werkzeug und Formenbau GmbH in Bavaria, Germany, which is assisted by Yizumi FF120 electric injection molding machine .
Announcement of Qingyuan Market Supervision and Administration Bureau on Food Safety Supervision and Sampling Information for the 19th Issue of 2022 (Production Link Tasks
Time of Update: 2022-08-19
xls According to the requirements of Qingyuan City's 2022 Food Safety Sampling Inspection Work Plan, Qingyuan Municipal Market Supervision and Administration Bureau recently organized sampling inspections of health food, biscuits, dairy products, cakes, other foods, meat products, food additives, tea and related products, edible oils and fats and other products.
BASF's E-TPU material is used in a new generation of pet toys
Time of Update: 2022-08-18
The innovative pet toy series will be exhibited at the 2019 Las Vegas Pet Supplies Show during August 20-22 (Booth: 6268) Plymouth Foam has launched AIREHIDE®, a new brand of canine toys made from BASF's Infinergy® material .
Accelerating the localization of adiponitrile will help further broaden the downstream demand pattern of butadiene
Time of Update: 2022-03-15
According to tracking data, in 2020 , China's butadiene downstream consumption structure will still occupy the main position in butadiene rubber, styrene butadiene rubber, SBS and ABS .
CSPC submitted desvenlafaxine succinate sustained-release tablet marketing applicant Fu has been approved for clinical use
Time of Update: 2022-03-09
Figure 2: Earlier application of domestic generic drugs for desvenlafaxine succinate sustained-release tabletsSource: One-click retrieval from MinetIn 2019, Renfu Pharmaceutical was the first to apply for a Category 3 generic marketing application for desvenlafaxine succinate sustained-release tablets, and it was finally approved for clinical use.
China's innovative drug Nerlik® is launched to break the drug-resistant dilemma of CML-resistant patients
Time of Update: 2021-12-26
Chen Kaixian, academician of the Chinese Academy of Sciences and deputy chief technical engineer of major new drug creation, said in an interview with reporters on the 19th: "Nelic® is China's third-generation BCR-ABL inhibitor, which effectively solves China's drug-resistant chronic myelogenous leukemia.